trending topics
market reports
- 
  MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations2025-02-17 
- 
  Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!2023-09-01 
- 
  US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight2022-01-21 
- 
  Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines2022-01-21 
- 
  Hong Kong researchers say they develop novel material able to kill COVID-19 virus2022-01-14 
- 
  10 million more Chinese doses on way for Kenya2022-01-14 
- 
  Sino-African ties on track for a brighter future2022-01-07 
- 
  Efforts urged to boost COVID-19 vaccine production capacity in poor countries2022-01-07 
- 
  UAE approves Sinopharm's new protein-based COVID-19 vaccine2022-01-07 
- 
  UAE approves Sinopharm's new protein-based COVID-19 vaccine2022-01-07 
- 
  Hospitals to beef up TCM usage to boost integration with Western medicineAll tertiary general hospitals in China will be required to set up a traditional Chinese medicine department, and all secondary hospitals will be encouraged to build TCM departments, a health official said on Friday. 2021-07-26
- 
  Researchers share results from ongoing municipal science and technology projectShanghai has achieved major breakthroughs in future intelligent technology fields, researchers in charge of a major municipal science and technology project said on Saturday. 2021-07-13
- 
  Study: Effective vaccine response among youngThe domestic COVID-19 vaccine developed by Sinovac Biotech is safe and can elicit a strong antibody response in people aged 3 to 17 in early and mid-stage clinical trials, according to a study published recently in a medical journal. 2021-07-12
- 
  Sinovac vaccine 'well tolerated, safe and induced humoral responses' in minors aged 3-17The world's first trial results on minors aged 3-17 showed China's inactivated COVID-19 vaccine produced by Sinovac had good safety, tolerability, and immunogenicity in youths aged 3-17 years, the Global Times learnt from Sinovac on Tuesday. 2021-06-30
- 
  Efficacy of Sinopharm vaccines tops 70%, study findsDomestic drugmaker Sinopharm's two vaccines are both more than 70 percent effective against symptomatic cases of COVID-19, according to a study published on Wednesday on the world's first third-stage clinical trial of inactivated vaccines. 2021-05-28
- 
  China's innovative lung cancer drug application accepted for review by US FDAChinese drugmaker Innovent Biologics, Inc. and the US-based pharmaceutical firm Eli Lilly and Company announced that FDA accepted for review an application for Sintilimab, an innovative lung cancer drug jointly developed by the two companies. 2021-05-25FDA
- 
  TCM soup can help cut COVID-19 death rate of patients in half, study showsQingfei paidu soup, a widely used traditional Chinese medicine to treat COVID-19 infections, can help reduce the rate of death among hospitalized patients by half, a recent study has shown. 2021-05-10
- 
  Fosun helps world fight malariaFosun Pharma has supplied more than 200 million doses of anti-malaria drugs to the international society since 2005 to help with the world's malaria elimination efforts, the company said on Sunday, which marked World Malaria Day. 2021-04-27
- 
  Vaccine production site opens in Tianjin2021-04-27
- 
  China's CanSino to offer tens of millions of COVID-19 vaccines to COVAXBEIJING - China's CanSino Biologics Inc has proposed providing "tens of million of doses" of its single-dose COVID-19 vaccine to global vaccine sharing scheme COVAX, Reuters quoted a senior executive of the company as saying. 2021-04-01
 
               
               
               My Member
My Member Message Center
Message Center 
                 
               
                 
                         
                             
                    